Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Sell

Analyst Rating

Strong Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Sell

Wall Street Data Solutions Rating

Sell

C

Inari Medical, Inc. Common Stock (NARI)

Surgical & Medical Instruments & Apparatus

https://www.inarimedical.com

Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from Chronic Venous Disease. Its product portfolio includes ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTriever System product is used for the treatment of pulmonary embolism. The company generates revenue from the sale of ClotTriever and FlowTriever systems directly to hospitals located in the United States. Majority of revenue is generated from FlowTriever system.

6001 OAK CANYON, SUITE 100
IRVINE, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

05/22/2020

Market Cap

2,846,910,962

Shares Outstanding

57,590,000

Weighted SO

57,590,463

Total Employees

N/A

Upcoming Earnings

08/07/2024

Similar Tickers

SWAV --.--%

OM --.--%

LEGN --.--%

PGNY --.--%

AXNX --.--%

Beta

1.0120

Last Div

0.0000

Range

36.73-70.25

Chg

-0.7900

Avg Vol

842770

Mkt Cap

2846910962

Exch

NASDAQ

Country

US

Phone

877 923 4747

DCF Diff

87.8851

DCF

-38.2351

Div Yield

0.0000

P/S

5.2001

EV Multiple

-574.8502

P/FV

6.7031

Div Yield %

0.0000

P/E

-49.7913

PEG

-0.5254

Payout

0.0000

Current Ratio

1.8035

Quick Ratio

1.4465

Cash Ratio

0.5077

DSO

54.4233

DIO

240.0506

Op Cycle

294.4738

DPO

79.6375

CCC

214.8363

Gross Margin

0.8629

Op Margin

-0.0591

Pretax Margin

-0.0641

Net Margin

-0.1042

Eff Tax Rate

-0.6257

ROA

-0.0848

ROE

-0.1276

ROCE

-0.0605

NI/EBT

1.6257

EBT/EBIT

1.0851

EBIT/Rev

-0.0591

Debt Ratio

0.0493

D/E

0.0782

LT Debt/Cap

0.0686

Total Debt/Cap

0.0725

Int Coverage

-286.2212

CF/Debt

0.8267

Equity Multi

1.5878

Rec Turnover

6.7067

Pay Turnover

4.5833

Inv Turnover

1.5205

FA Turnover

7.6219

Asset Turnover

0.8136

OCF/Share

0.4713

FCF/Share

0.2908

Cash/Share

1.8874

OCF/Sales

0.0501

FCF/OCF

0.6169

CF Coverage

0.8267

ST Coverage

14.2883

CapEx Coverage

2.6105

Div&CapEx Cov

2.6105

P/BV

6.7031

P/B

6.7031

P/S

5.2001

P/E

-49.7913

P/FCF

168.3865

P/OCF

103.6614

P/CF

103.6614

PEG

-0.5254

P/S

5.2001

EV Multiple

-574.8502

P/FV

6.7031

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jul 06, 20:12 Inari Medical (NARI) Faces DOJ Probe and Investor Backlash Amid Kickback Allegations– Hagens Berman - GlobeNewswire GlobeNewswire Inc. Jan 09, 06:30 Inari Medical Announces Preliminary 2023 Revenue and 2024 Guidance MarketWatch Dec 28, 07:46 Here's a 'solid contrarian idea' for 2024, according to BTIG's Krinsky MarketWatch Dec 28, 06:34 Here's a 'solid contrarian idea' for 2024, according to BTIG's Krinsky GlobeNewswire Inc. Nov 27, 16:20 Inari Medical Announces First Patient Enrollment in PEERLESS II Randomized Controlled Trial (RCT) GlobeNewswire Inc. Nov 27, 16:20 Inari Medical Announces First Patient Enrollment in PEERLESS II Randomized Controlled Trial (RCT)

Revenue Product Segmentation